SM Kukil

078130 · KOSDAQ · ₩078130 · 에스엠국일

₩3,380▲ ₩25 (0.75%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about SM Kukil

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

SM Kukil is loss-making on a trailing basis, with a merger, CEO change and short-term borrowing decisions filed in recent months.

Kukil is a Korean specialty paper maker, mainly for tobacco-related and interlining paper, with an early-stage graphene subsidiary that has no product sales yet. Over the last twelve months to H1 2026 it reported revenue of about ₩62.7B, an operating loss of ₩1.3B and a net loss of ₩3.9B. The share price closed at ₩3,515 on 2026-10-23, down 18.1% over one year and about 41% below the 52-week high.

What stands out

  • Trailing revenue of ₩62.7B is below 2025's ₩67.8B, and the trailing net margin is -6.2%.
  • Losses have narrowed from 2023 and 2024, when operating margins were -9.2% and -2.3%, but the company has not been profitable in the years shown.
  • Cash of ₩16.0B is reported, the liabilities-to-equity ratio is 9.8%, and no borrowings figure is given in the data.
  • Price-to-book is 3.3, while P/E is not meaningful because earnings are negative; the company pays no dividend.
  • Foreign ownership is 0%, and 20-day flows were net retail selling of about ₩1.8B, with institutions net buying about ₩1.2B.

What to watch

  • Filings show a merger decision (September 2026), an amended merger attachment, a shareholders' meeting and a record date, so the terms and timing of the merger matter.
  • An October 2026 decision on increasing short-term borrowings and a 'major management matter' filing are not explained in the data and should be checked in the full filings.
  • Whether graphene development reaches commercial sales, since none is recorded yet; no news headlines were available in the data.

Data as of Oct 23, 2026 · written 5d ago

This is not financial advice.

Also known as: SM Kukil / 에스엠국일 / 078130 / KRX:078130

Source: KRX statistical information